Dry Eye clinical trials at University of California Health
2 in progress, 1 open to eligible people
Showing trials for
Azithromycin for Meibomian Gland Disease
open to eligible people ages 18 years and up
This study aims to elucidate the effectiveness of oral azithromycin in treating symptomatic dry eye syndrome secondary to Meibomian gland dysfunction.
Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA)
Sorry, accepting new patients by invitation only
This study is designed to measure how common nerve abnormalities are within a group of patients who feel discomfort within their eyes.
Our lead scientists for Dry Eye research studies include Julie Schallhorn, MD, MS Thuy Doan, MD, PhD.